CN
CN EN
Recombinant Human Interferon α1b for Injection
Recombinant Human Interferon α1b for Injection (trade name: SINOGEN), included in the National Essential Medicines List and the National Reimbursement Drug List (category B), has broad-spectrum antiviral, antitumor, and immunoregulatory effects.